Aiuto accessibilità | Mappa del sito | Contatto | Assistenza clienti
Home  |  Patologie  |  Prodotti  |  Evidenze cliniche  |  Formazione e Training  |  Per i pazienti  |  Assistenza clienti
Siete qui Home > Notizie e Media > Acelity Increases Focus on Growth, Expansion Opportunities

Acelity Increases Focus on Growth, Expansion Opportunities

Distribuzione : 30 Novembre 2015

 Appoints Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing

KCI, Leader in Advanced Wound Care Solutions

SAN ANTONIO, November 30, 2015 – Acelity L.P. Inc. announced today the appointment of Dennis Crowley as Senior Vice President, Strategy, Business Development and Licensing (SBD&L). Dennis joins Acelity as a member of the senior leadership team. 


In this position, Dennis will oversee strategic planning, portfolio management and business development including M&A, partnerships, alliances and other activities that support Acelity’s growth strategy. Dennis brings to Acelity more than 20 years of experience in guiding mergers and acquisitions, joint ventures and strategic affiliations in all regions of the world. His deep expertise in corporate transactions and demonstrated leadership abilities make him especially well-suited to working across countries and franchises to identify and aggressively pursue opportunities on behalf of Acelity.


“We have achieved significant results against our strategic imperative as we seek to establish Acelity as a global leader in medical technology,” said Joe Woody, President and CEO, Acelity. “As Acelity enters the next phase of its transformative journey, Dennis’ proven track record in leading business development and strategy make him a natural fit to drive and execute on our vision for growth in business segments and geographies around the world.”


Dennis joins Acelity from Medtronic and led previously the Covidien Global Business Development team prior to that merger, supporting business units and geographies while identifying new market opportunities. He is a graduate of Harvard College with a degree in Economics.


About Acelity

Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,700 people around the world.


For more information, contact:

Cheston Turbyfill
Corporate Communications
Phone: +1-210-515-7757
Caleb Moore
Investor Relations
Phone: +1-210-255-6433


  • Condividi su
  • Condividi su Twitter
  • Visita il nostro canale su YouTube

Messaggi importanti per i pazienti

Avviso legale | Informativa sulla privacy | Contatto

KCI Medical S.r.l. con socio unico (soggetta a direzione e coordinamento di KCI UK Holdings Ltd.)
Capitale sociale 4.900.000 Euro (i.v.) – P.IVA / C.F. 10804870151 – Registro Imprese MI n. 330579 – REA/CCIAA MI 1406540

Le informazioni contenute in questo sito sono destinate esclusivamente agli operatori sanitari.

Le informazioni contenute in questo sito si intendono solo per i clienti italiani.

© 1998 – 2013 KCI Licensing, Inc. Tutti i diritti riservati.    DSL#09-02-193.IT
Le informazioni incluse in questo sito Web sono state concepite esclusivamente per l’Italia. Il presente sito Web contiene informazioni su prodotti che possono non essere disponibili nei diversi paesi e possono non aver ricevuto l'approvazione o l'autorizzazione all'immissione sul mercato dagli enti regolatori governativi per indicazioni o restrizioni diverse a seconda dei paesi.